Case series: Extrapyramidal symptoms associated with use of aripiprazole in older adults

International Journal of Geriatric Psychiatry

Volumn 28, Issue 11, 2013, Pages 1208-1210

  Sweeney, Eileen B ^a   Lawlor, Brian A ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; ARIPIPRAZOLE; DULOXETINE; MIRTAZAPINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; CASE STUDY; CLINICAL ARTICLE; DEPRESSION; DEPRESSIVE PSYCHOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; LETTER; MALE; PARKINSONISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SEX RATIO; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; FEMALE; HUMANS; MALE; PIPERAZINES; QUINOLONES; RISK FACTORS;

EID: 84885611340     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3964     Document Type: Letter

References (5)

1. DeKeyser J, Ebinger G, Vauquelin G,. 1990. Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol 27: 157-161.
2. Heusler P, Newman-Tancredi A, Loock T, Cussac D,. 2008. Antipsychotics differ in their ability to internalise human dopamine D2s and human serotonin 5-HT1A receptors in HEK293 cells. Eur J Pharmacol 581: 37-46.
3. Kinirons MT, O'Mahony MS,. 2004. Drug metabolism and ageing. BJCP 57: 540-544.
4. Rutherford B, Sneed J, Miyazaki M, et al,. 2007. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. Int J Geriatr Psychiatry 22: 986-991.
5. Steffens DC, Nelson JC, Eudicone JM, et al,. 2011. Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis. Int J Geriatr Psychiatry 26: 564-572.